Form 4: STAAR Surgical COO Warren Foust Reports Stock Transactions
SEC Form 4 Filing
Warren Foust, COO of STAAR Surgical, reports the vesting and disposal of restricted stock units.
Summary
- Warren Foust, the Chief Operating Officer of STAAR Surgical, filed a Form 4 with the SEC.
- The report details the vesting of 8,175 restricted stock units (RSUs) on March 12, 2025, which were then disposed of.
- These RSUs were granted on March 12, 2024, and vest in three equal installments annually.
- Following the reported transactions, Foust beneficially owns 26,088 shares of common stock, including previously granted RSUs subject to future vesting, and 16,350 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company insider, and it doesn't inherently indicate positive or negative sentiment.
Future Outlook
The remaining RSUs will vest in two equal installments on March 12, 2026, and March 12, 2027.
Industry Context
Form 4 filings are routine disclosures for company insiders and provide transparency regarding their transactions in the company's stock.
Stakeholder Impact
- The vesting of RSUs has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date the restricted stock units (RSUs) were granted to Warren Foust. |
| 03/12/2025 | Date that 1/3 (8,175 shares) of the RSUs vested. |
| 03/14/2025 | Date of the report. |
| 03/12/2026 | Date that 1/3 (8,175 shares) of the RSUs will vest. |
| 03/12/2027 | Date that 1/3 (8,175 shares) of the RSUs will vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.